L193 (Ropinirole Hydrochloride Extended-Release 4 mg)
Pill with imprint L193 is Brown, Capsule-shape and has been identified as Ropinirole Hydrochloride Extended-Release 4 mg. It is supplied by Trigen Laboratories, Inc.
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L193
Ropinirole Hydrochloride Extended-Release
- Imprint
- L193
- Strength
- 4 mg
- Color
- Brown
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Trigen Laboratories, Inc.
- National Drug Code (NDC)
- 13811-0640 (Discontinued)
- Inactive Ingredients
-
hypromelloses,
hydrogenated castor oil,
carboxymethylcellulose sodium,
corn starch,
povidone,
silicon dioxide,
magnesium stearate,
ethylcellulose (7 mPa.s),
titanium dioxide,
polyethylene glycol 8000,
ferric oxide yellow,
ferric oxide red
Note: Inactive ingredients may vary.
Related images for "L193"
More about ropinirole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (311)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.